Academic cancer programs deliver improved long-term survival in nodular lymphocyte predominant Hodgkin lymphoma: Insights from 7,000+ United States patients
Retrospective analysis shows improved survival rates in Hodgkin lymphoma patients treated at academic centers, indicating disparities in cancer care.
Key Points
This research examines survival outcomes in patients with nodular lymphocyte predominant Hodgkin lymphoma treated at academic versus community cancer programs.
Conducted a retrospective analysis using the National Cancer Database.
Compared demographic, clinical features, and survival data between patients at academic and community cancer programs.
Utilized Kaplan-Meier and Cox proportional hazards models for overall survival analysis.
Patients treated at academic cancer programs had higher overall survival rates compared to those at community programs.
Two-, five-, and ten-year survival rates were significantly better in patients treated at academic centers (96% vs. 93%, 90% vs. 87%, 81% vs. 77%).
Differences observed in demographics include a higher proportion of Black patients treated at academic centers.